Sfoglia per Autore
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update
2024-01-01 Roccuzzo, Gabriele; Bongiovanni, Eleonora; Tonella, Luca; Pala, Valentina; Marchisio, Sara; Ricci, Alessia; Senetta, Rebecca; Bertero, Luca; Ribero, Simone; Berrino, Enrico; Marchiò, Caterina; Sapino, Anna; Quaglino, Pietro; Cassoni, Paola
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
2023-01-01 Rubatto Marco; Borriello Silvia; Sciamarrelli Nadia; Pala Valentina; Tonella Luca; Ribero Simone; Quaglino Pietro
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
2022-01-01 Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro
Infections in Sézary syndrome: A retrospective cohort study of 113 patients
2022-01-01 Cariti C.; Quaglino P.; Lupia T.; Novelli M.; Marra E.; Fava P.; Caliendo V.; Tonella L.; De Rosa F.G.; Fierro M.T.; Ribero S.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
2022-01-01 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
2022-01-01 Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A.
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study
2022-01-01 Amabile, Simone; Tonella, Luca; Rubatto, Marco; Argenziano, Giuseppe; Babino, Graziella; Frascione, Pasquale; Dika, Emi; Giacomelli, Luca; Parodi, Aurora; Quaglino, Pietro
Alopecia areata after COVID-19 vaccination
2022-01-01 Gallo G.; Mastorino L.; Tonella L.; Ribero S.; Quaglino P.
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
2021-01-01 Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S.
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma
2021-01-01 Liberini V.; Rubatto M.; Mimmo R.; Passera R.; Ceci F.; Fava P.; Tonella L.; Polverari G.; Lesca A.; Bello M.; Arena V.; Ribero S.; Quaglino P.; Deandreis D.
Nutritional interventions for patients with melanoma: From prevention to therapy—an update
2021-01-01 Pellegrini M.; D'eusebio C.; Ponzo V.; Tonella L.; Finocchiaro C.; Fierro M.T.; Quaglino P.; Bo S.
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials
2021-01-01 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
2021-01-01 Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P.
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications
2021-01-01 Tonella L.; Pala V.; Ponti R.; Rubatto M.; Gallo G.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Fava P.; Bertero L.; Senetta R.; Osella-Abate S.; Ribero S.; Fierro M.T.; Quaglino P.
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit
2021-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study
2021-01-01 Barreiro-Capurro A.; Andres-Lencina J.J.; Podlipnik S.; Carrera C.; Requena C.; Manrique-Silva E.; Quaglino P.; Tonella L.; Jaka A.; Richarz N.; Rodriguez-Peralto J.L.; Ortiz P.; Boada A.; Ribero S.; Nagore E.; Malvehy J.; Puig S.
Treatment of Advanced Metastatic Melanoma
2021-01-01 Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Fierro, Maria Teresa
Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience
2020-01-01 Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT.
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit
2020-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update | 2024 | Roccuzzo, Gabriele; Bongiovanni, Eleonora; Tonella, Luca; Pala, Valentina; Marchisio, Sara; Ricci, Alessia; Senetta, Rebecca; Bertero, Luca; Ribero, Simone; Berrino, Enrico; Marchiò, Caterina; Sapino, Anna; Quaglino, Pietro; Cassoni, Paola | |
| Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies | 2023 | Rubatto Marco; Borriello Silvia; Sciamarrelli Nadia; Pala Valentina; Tonella Luca; Ribero Simone; Quaglino Pietro | |
| Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer | 2022 | Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro | |
| Infections in Sézary syndrome: A retrospective cohort study of 113 patients | 2022 | Cariti C.; Quaglino P.; Lupia T.; Novelli M.; Marra E.; Fava P.; Caliendo V.; Tonella L.; De Rosa F.G.; Fierro M.T.; Ribero S. | |
| Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study | 2022 | Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P. | |
| CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study | 2022 | Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A. | |
| Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study | 2022 | Amabile, Simone; Tonella, Luca; Rubatto, Marco; Argenziano, Giuseppe; Babino, Graziella; Frascione, Pasquale; Dika, Emi; Giacomelli, Luca; Parodi, Aurora; Quaglino, Pietro | |
| Alopecia areata after COVID-19 vaccination | 2022 | Gallo G.; Mastorino L.; Tonella L.; Ribero S.; Quaglino P. | |
| Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome | 2021 | Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S. | |
| Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma | 2021 | Liberini V.; Rubatto M.; Mimmo R.; Passera R.; Ceci F.; Fava P.; Tonella L.; Polverari G.; Lesca A.; Bello M.; Arena V.; Ribero S.; Quaglino P.; Deandreis D. | |
| Nutritional interventions for patients with melanoma: From prevention to therapy—an update | 2021 | Pellegrini M.; D'eusebio C.; Ponzo V.; Tonella L.; Finocchiaro C.; Fierro M.T.; Quaglino P.; Bo S. | |
| Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. | |
| Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
| Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives | 2021 | Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications | 2021 | Tonella L.; Pala V.; Ponti R.; Rubatto M.; Gallo G.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Fava P.; Bertero L.; Senetta R.; Osella-Abate S.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit | 2021 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T. | |
| Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study | 2021 | Barreiro-Capurro A.; Andres-Lencina J.J.; Podlipnik S.; Carrera C.; Requena C.; Manrique-Silva E.; Quaglino P.; Tonella L.; Jaka A.; Richarz N.; Rodriguez-Peralto J.L.; Ortiz P.; Boada A.; Ribero S.; Nagore E.; Malvehy J.; Puig S. | |
| Treatment of Advanced Metastatic Melanoma | 2021 | Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Fierro, Maria Teresa | |
| Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience | 2020 | Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. | |
| Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit | 2020 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile